Tinnitus and its current treatment-Still an enigma in medicine

Journal of the Formosan Medical Association

Volumn 115, Issue 3, 2016, Pages 139-144

  Swain, Santosh Kumar ^a   Nayak, Saumyadarshan ^a   Ravan, Jayprakash Russel ^b   Sahu, Mahesh Chandra ^a  

^a SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

^b Dept of Biochemistry KIIMS BBSR   (India)

Author keywords

Pathophysiology; Tinnitus; Tinnitus retraining therapy; Treatment

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BENZODIAZEPINE DERIVATIVE; BETA CAROTENE; BETAHISTINE; CAROVERINE; LIDOCAINE; MAGNESIUM; MELATONIN; METHIONINE; NERAMEXANE; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT; VESTIPITANT; VITAMIN B GROUP; ZINC;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ANALGESIC ACTIVITY; AUDITORY CORTEX; COCHLEA BLOOD FLOW; COCHLEA PROSTHESIS; COGNITIVE THERAPY; COMORBIDITY; DIETARY INTAKE; DIRECTIVE COUNSELING; DISEASE SEVERITY; FEEDBACK SYSTEM; GENE THERAPY; GINKGO BILOBA; HEARING AID; HUMAN; PATHOPHYSIOLOGY; PHARMACEUTICAL CARE; QUALITY OF LIFE; REVIEW; STEM CELL TRANSPLANTATION; TINNITUS; COUNSELING; HEARING; RISK FACTOR;

AUDITORY PERCEPTION; COGNITIVE THERAPY; COUNSELING; HUMANS; RISK FACTORS; TINNITUS;

EID: 84960438473     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2015.11.011     Document Type: Review

References (37)

1. Crummer R.W., Hassan G.A. Diagnostic approach to tinnitus. Am Fam Physician 2004, 69:120-126.
2. Atik A. Pathophysiology and treatment of tinnitus: an elusive disease. Indian J Otolaryngol Head Neck Surg 2014, 66:1-5.
3. Lockwood A.H. Tinnitus. Neurol Clin 2005, 23:893-900.
4. Henry J.A., Dennis K.C., Schechter M.A. General review of tinnitus: prevalence, mechanisms, effects and management. J Speech Hear Res 2005, 48:1204-1235.
5. Qiu C., Salvi R., Ding D., Burkard R. Inner hair cell loss leads to enhanced response amplitudes in auditory cortex of unanesthetized chinchillas: evidence for increased system gain. Hear Res 2000, 139:153-171.
6. Fortune D.S., Haynes D.S., Hall J.W. Tinnitus: current evaluation and management. Med Clin North Am 1999, 83:153-162.
7. Clausson C.F. Rakel & Bope: Conn's current therapy 2008, Elsevier Inc, Philadelphia. 60th ed.
8. Langguth B., Salvi R., Elgoyhen A.B. Emerging pharmacotherapy of tinnitus. Expert Opin Emerg Drugs 2009, 14:687-702.
9. Krog N.H., Engdahl B., Tambs K. The association between tinnitus and mental health in a general population sample: results from the HUNT Study. J Psychosom Res 2010, 69:289-298.
10. Xu X., Bu X., Zhou L., Xing G., Liu C., Wang D. An epidemiologic study of tinnitus in a population in Jiangsu Province, China. J Am Acad Audiol 2011, 22:578-585.
11. Hoff man H.J., Reed G.W. Epidemiology of tinnitus. Tinnitus: theory and management 2004, 16-41. BC Decker, London. J.B. Snow (Ed.).
12. Roberts L.E., Eggermont J.J., Caspary D.M., Shore S.E., Melcher J.R., Kaltenbach J.A. Ringing ears: the neuroscience of tinnitus. J Neurosci 2010, 30:14972-14979.
13. Helfer T.M. Noise-induced hearing injuries, active component, US Armed Forces, 2007-2010. MSMR 2011, 18:7-10.
14. Trellakis S., Lautermann J., Lehnerdt G. Lidocaine: neurobiological targets and effects on the auditory system. Prog Brain Res 2007, 166:303-322.
15. Mico J.A., Denis A., Esther B., Alain E. Antidepressants and pain. Trends Pharmacol Sci 2006, 27:348-354.
16. Moller A.R. Tinnitus and pain. Prog Brain Res 2007, 166:47-53.
17. Sullivan M., Wayne K., Joan R., Robert D., Connie S. A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med 1993, 153:2251-2259.
18. Langguth B., Peter K.M., Kleinjung T., Dirk R.D. Tinnitus: causes and clinical management. Lancet Neurol 2013, 12:920-930.
19. Baguley D., Mc Ferran D., Hall D. Tinnitus. Lancet 2013, 382:1600-1607.
20. Domeisen H., Hotz M.A., Hausler R. Caroverine in tinnitus treatment. Acta Otolaryngol 1998, 118:606-608.
21. Rejali D., Sivakumar A., Balaji N. Ginkobiloba does not benefit patients with tinnitus: a randomized placebo-controlled, double blind trial and meta-analysis of randomized trials. Clin Otolaryngol Allied Sci 2004, 29:226-231.
22. James A.L., Burton M.J. Betahistine for Menière's disease or syndrome. Cochrane Database Syst Rev 2001, 1:CD001873.
23. Davies E., Knox E., Donaldson I. The usefulness of nimodipine, an l-calcium channel antagonist, in the treatment of tinnitus. Br J Audiol 1994, 28:125-129.
24. Andersson G., Lyttkens L. A meta-analytic review of psychological treatment for tinnitus. Br J Audiol 1999, 33:201-210.
25. Henry J.A., Schechter M.A., Zaugg T.L., Griest S., Jastreboff P.J., Vernon J.A., et al. Outcomes of clinical trial: tinnitus masking versus tinnitus retraining therapy. J Am Acad Audiol 2006, 17:104-132.
26. Berry J.A., Gold S.L., Frederick E.A., Gray W.C., Staecker H. Patient based outcomes in patients with primary tinnitus undergoing tinnitus retraining therapy. Arch Otolaryngol Head Neck Surg 2002, 128:1153-1157.
27. Zachriat C., Korner-Herwig B. Treating chronic tinnitus: comparison of cognitive behavioural and habituation based treatments. Cogn Behav Ther 2004, 33:187-198.
28. Baguley D.M., Atlas M.D. Cochlear implants and tinnitus. Prog Brain Res 2007, 166:347-355.
29. Dobie R.A. A review of randomized clinical trials in tinnitus. Laryngoscope 1999, 109:1202-1211.
30. Coles R. Therapeutic blind alleys. Tinnitus treatment and relief 1998, 8-19. Allyn and Bacon, Needham Heights. J.A. Vernon (Ed.).
31. Costen J.B. A syndrome of ear and sinus symptoms dependent upon disturbed function of the temporomandibular joint. Ann Otol Rhinol Laryngol 1997, 106:805-819.
32. Huang Y.F., Lin J.C., Yang H.W., Lee Y.H., Yu C.H. Clinical effectiveness of laser acupuncture in the treatment of temporomandibular joint disorder. J Formos Med Assoc 2014, 113:535-539.
33. Liu H.B., Fan J.P., Lin S.Z., Zhao S.W., Lin Z. Botox transient treatment of tinnitus due to stapedius myoclonus: case report. Clin Neurol Neurosurg 2011, 113:57-58.
34. Sun W., Ding D.L., Wang P., Sun J., Jin X., Salvi R.J. Substance P inhibits potassium and calcium currents in inner ear spiral ganglion neurons. Brain Res 2004, 1012:82-83.
35. Plazas P.V., Savino J., Kracun S., Gomez-Casati M.E., Katz E., Parsons C.G., et al. Inhibition of the alpha 9 alpha 10 nicotinic cholinergic receptor by neramexane, an open channel blocker of the N-methyl -d-asparate receptors. Eur J Pharmacol 2007, 566:11-19.
36. Cotanche D.A. Genetic and pharmacological intervention for treatment/prevention of hearing loss. J Commun Disord 2008, 41:421-443.
37. Campbell K., Claussen A., Meech R., Verhulst S., Fox D., Hughes L. D-methionine (D-met) significantly rescues noise-induced hearing loss: timing studies. Hear Res 2011, 282:138-144.